Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, Siteman Cancer Center, 4960 Children's Place, Campus Box 8242, St Louis, MO 63110, USA.
Urol Clin North Am. 2010 Feb;37(1):1-9, Table of Contents. doi: 10.1016/j.ucl.2009.11.004.
The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.
关于基于人群的前列腺癌筛查是否有用的争论已经持续了几十年。目前最有力的证据表明，人群筛查的获益有限，却带来显著的心理、身体和经济负担。通过使用更好的标志物和更具选择性的治疗来改进筛查，可能会使基于人群的筛查更为有效。
